Kyung-Sang Yu (Kyung Sang Yu)

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 46

Top Topics

Placebo Controlled

Top Venues

Clinical and translational science

Translational and clinical pharmacology

Drug design, development and therapy

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Jiang, Sungyeun Bae, Deok Yong Yoon, Shin Jung Park, Jaeseong Oh, Joo-Youn Cho, Kyung-Sang Yu
Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects. Drug design, development and therapy 17 (2023)
Bo Rim Kim, Leerang Lim, YoungRok Choi, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Kyung-Sang Yu, Jin Young Sohn, Raewon Jeong, Jaeseong Oh, Ho Geol Ryu
Continuous versus Intermittent Infusion of Human Antithrombin III Concentrate in the Immediate Postoperative Period after Liver Transplantation. Clinical and translational science (2023)
Ki Young Huh, Woo Kyung Chung, Jiyeon Park, Seung Hwan Lee, Min Gul Kim, Jaeseong Oh, Kyung-Sang Yu
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms. Clinical and translational science (2023)
Inyoung Hwang, Sang Chun Ji, Jaeseong Oh, Hyojin Kim, Hyunju Cha, John Kim, Chang-Seok Lee, Kyung-Sang Yu, Seung Hwan Lee
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects. Alimentary pharmacology & therapeutics 57 (7) (2023)
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In-Jin Jang, Kyung-Sang Yu, Jaeseong Oh
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. Clinical and translational science (2023)
Inyoung Hwang, Sang Chun Ji, Jaeseong Oh, Hyojin Kim, Hyunju Cha, John Kim, Chang-Seok Lee, Kyung-Sang Yu, Seung Hwan Lee
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects. Alimentary pharmacology & therapeutics (2023)
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In-Jin Jang, Kyung-Sang Yu, Jaeseong Oh
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. Clinical and translational science (2023)
Sungyeun Bae, Jihoon Kwon, Mi-Hye Lee, Kyung-Sang Yu, Seung Hwan Lee
Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole. Drug design, development and therapy 17 (2023)
Ki Young Huh, Hwiwon Lee, Seung Hwan Lee, Kyung-Sang Yu, Kyung Hwan Kim, Heejin Kim
Exploration of smart adherence-monitoring methods in vitamin D-deficient patients: A pilot, feasibility clinical study. Clinical and translational science (2023)
Inyoung Hwang, Sang Chun Ji, Jaeseong Oh, Hyojin Kim, Hyunju Cha, John Kim, Chang-Seok Lee, Kyung-Sang Yu, Seung Hwan Lee
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects. Alimentary pharmacology & therapeutics 57 (7) (2023)
Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In-Jin Jang, Kyung-Sang Yu, Jaeseong Oh
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. Clinical and translational science (2023)
Sungyeun Bae, Jihoon Kwon, Mi-Hye Lee, Kyung-Sang Yu, Seung Hwan Lee
Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole. Drug design, development and therapy 17 (2023)
Ki Young Huh, Kyung-Sang Yu, Ildae Song
Analysis of the distribution of trial sites in South Korea using social network analysis. Translational and clinical pharmacology 31 (1) (2023)
Eunsol Yang, Seokuee Kim, Bongtae Kim, Boram Kim, Yechan Kim, Sung Sup Park, Geun Seog Song, Kyung-Sang Yu, In-Jin Jang, SeungHwan Lee
Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole. British journal of clinical pharmacology 88 (7) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science 16 (3) (2022)
Byungwook Kim, Ki Young Huh, Jun Gi Hwang, Jae Jin Nah, Wan Huh, Jae Min Cho, In-Jin Jang, Kyung-Sang Yu, Yun Kim, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Interaction Between DWP16001, an SGLT2 Inhibitor, and Metformin in Healthy Subjects. British journal of clinical pharmacology (2022)
Bonah Kim, Hee Young Kim, Bo Ruem Yoon, Jina Yeo, Ji In Jung, Kyung-Sang Yu, Hyeon Chang Kim, Su-Jin Yoo, Jin-Kyun Park, Seong Wook Kang, Won Woo Lee
Cytoplasmic zinc promotes IL-1β production by monocytes and macrophages through mTORC1-induced glycolysis in rheumatoid arthritis. Science signaling 15 (716) (2022)
Jun Gi Hwang, Seung Hwan Lee, Wan Huh, Jumi Han, Jaeseong Oh, In-Jin Jang, Kyung-Sang Yu
Dose-dependent glucosuria of DWP16001, a novel selective sodium-glucose cotransporter-2 inhibitor, in healthy subjects. British journal of clinical pharmacology 88 (9) (2022)
Sungyeun Bae, JungJin Oh, Ildae Song, Kyung-Sang Yu, Seung Hwan Lee
Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs. Translational and clinical pharmacology 30 (3) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science 16 (3) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science (2022)
Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Sang-Ku Yoo, Youngah Kim, Jaeseong Oh
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human study. Clinical and translational science 15 (11) (2022)
Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh
Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers. Clinical and translational science (2022)
Eunsol Yang, Hyounggyoon Yoo, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study. Drug design, development and therapy 15 (2021)
Inseung Jeon, Jaeseong Oh, Yu-Kyung Kwon, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP®) Biosimilar, to Those of NESP® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects. Drug design, development and therapy 15 (2021)
Sungyeun Bae, Jihoon Kwon, Si-Beum Lee, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole. Drug design, development and therapy 15 (2021)
Jihyun Jung, Soyoung Lee, Jaeseong Oh, Seung Hwan Lee, In-Jin Jang, Donghwan Lee, Kyung-Sang Yu
Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Sangmi Lee, Eunwoo Kim, Seol Ju Moon, Jina Jung, Seung Hwan Lee, Kyung-Sang Yu
Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects. Translational and clinical pharmacology 29 (1) (2021)
Ki Young Huh, Hyewon Chung, Yu Kyong Kim, SeungHwan Lee, Siddharth Bhatia, Yohei Takanami, Ryou Nakaya, Kyung-Sang Yu
Evaluation of safety and pharmacokinetics of bismuth-containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. British journal of clinical pharmacology (2021)
Inseung Jeon, Yu-Kyong Kim, Ildae Song, Deok Yong Yoon, Ki Young Huh, Xuanyou Jin, Kyung-Sang Yu, Seung Hwan Lee, Yuji Kumagai, In-Jin Jang
The necessary conduct: Exploratory multiregional clinical trials in East Asia. Clinical and translational science 14 (6) (2021)
Ki Young Huh, Kyung-Sang Yu, Hyeong-Seok Lim, Hyungsub Kim
Trends of clinical trials from 2017 to 2019 in Korea: an integrated analysis based on the Ministry of Food and Drug Safety (MFDS) and the Clinical Research Information Service (CRIS) registries. Translational and clinical pharmacology 29 (4) (2021)
JuYeun Jeon, Jaeseong Oh, Kyung-Sang Yu
A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy. Translational and clinical pharmacology 29 (1) (2021)
Sejung Hwang, Dae Young Lee, Joo-Youn Cho, Jae-Yong Chung, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects. Drug design, development and therapy 15 (2021)
Byungwook Kim, Deok Yong Yoon, Seung Hwan Lee, In-Jin Jang, Kyung-Sang Yu, Joo-Youn Cho, Jaeseong Oh
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform. Translational and clinical pharmacology 29 (3) (2021)
JuYeun Jeon, Hyeikyoung Kim, Kyung-Sang Yu
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea. Journal of Korean medical science 35 (36) (2020)
Xuanyou Jin, Eunwoo Kim, Ki Young Huh, Inyoung Hwang, Joo-Youn Cho, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects. Translational and clinical pharmacology 28 (1) (2020)
Do-Yong Kim, Jangsup Moon, Yong-Won Shin, Soon Tae Lee, Keun Hwa Jung, Kyung-Il Park, Ki-Young Jung, Manho Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, KaHeon Song, Kon Chu, Sang Kun Lee
Usefulness of saliva for perampanel therapeutic drug monitoring. Epilepsia 61 (6) (2020)
Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects. Drug design, development and therapy 14 (2020)
Jung Sunwoo, Sang Chun Ji, Jaeseong Oh, Mu Seong Ban, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Kyung-Sang Yu, In-Jin Jang, Seung Hwan Lee
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Bo Rim Kim, Jaeseong Oh, Kyung-Sang Yu, Ho Geol Ryu
Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation. British journal of clinical pharmacology 86 (5) (2020)
Suhrin Lee, Seung Hwan Lee, In-Jin Jang, Kyung-Sang Yu, Su Jin Rhee
Electronic medical records-based comparison of glycemic control efficacy between sulfonylureas and dipeptidyl peptidase-4 inhibitors added on to metformin monotherapy in patients with type 2 diabetes. Translational and clinical pharmacology 28 (4) (2020)
Mu Seong Ban, Yu-Kyong Kim, Byungwook Kim, Jina Jung, Yong-Il Kim, Jaeseong Oh, Kyung-Sang Yu
Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers. Translational and clinical pharmacology 28 (4) (2020)
Eunsol Yang, Soyoung Lee, Heechan Lee, Inyoung Hwang, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects. Translational and clinical pharmacology 27 (4) (2019)
Sumin Yoon, Sojeong Yi, Su Jin Rhee, Hyun A Lee, Yun Kim, Kyung-Sang Yu, Jae-Young Chung
Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment. Translational and clinical pharmacology 27 (3) (2019)
Andrew HyoungJin Kim, Sumin Yoon, Yujin Lee, Jieon Lee, Eunjin Bae, Hajeong Lee, Dong-Ki Kim, Seung Hwan Lee, Kyung-Sang Yu, In-Jin Jang, Joo-Youn Cho
Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment. Journal of Korean medical science 33 (53) (2018)
Hyeon Jeong Suh, In Ho Kim, Joo-Youn Cho, Sang In Park, Seo Hyun Yoon, Jeong Ok Lee, Youngil Koh, Kyoung-Ho Song, Pyeong Gyun Choe, Kyung-Sang Yu, Eu-Suk Kim, Hong Bin Kim, Soo-Mee Bang, Nam Joong Kim, Sang Hoon Song, Pyoeng Gyun Choe, Myoung-don Oh
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies. Infection & chemotherapy 49 (2) (2017)
Yoon Ji Kim, Seongkeun Park, Wangjin Yi, Kyung-Sang Yu, Bongseong Kim, Tae Jung Oh, Jinwook Choi, Young Min Cho
Seasonal variation in hemoglobin a1c in korean patients with type 2 diabetes mellitus. Journal of Korean medical science 29 (4) (2014)